Banca Mediolanum S.p.A. (BMED.MI)
Basiglio, MI, IT
Banca Mediolanum S.p.A. is an Italian financial institution that delivers a broad spectrum of banking and financial solutions. Its offerings encompass fundamental services like checking accounts, diverse lending options including mortgages, and a variety of payment cards such as debit, credit, and prepaid. Additionally, the company facilitates wealth growth through savings instruments, investment vehicles like stocks and bonds, and brokerage services. Beyond traditional banking, it also provides insurance and retirement planning products. The organization was established in 1982, with its primary operations based in Basiglio, Italy.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.72% | +0.83% | +3.14% | +10.88% | +1.20% | -1.63% | +33.52% | +146.62% | +147.89% | +173.83% | +1,095.06% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 5 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth+69.7% Q1'26: +29.8% (vs Q1'25)
-
EPS growth+10.7% Q1'26: +12.1% (vs Q1'25)
-
FCF margin— Q1'26: +0.0% (vs Q1'25)
-
EBIT margin— Q1'26: +43.0% (vs Q1'25)
-
ROIC— Q1'26: +16.7% (vs Q1'25)
-
Share dilution+1.0% Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA— Q1'26: 1.22× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 7 EPS Ana. |
Dec 2027 5 Rev. Ana. 8 EPS Ana. |
Dec 2028 3 Rev. Ana. 6 EPS Ana. |
Dec 2029 2 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.74B
est: 2.55B (+85.6%)
|
3.77B
est: 1.58B (+137.9%)
|
3.43B
est: 1.51B (+126.8%)
|
2.17B
est: 1.43B (+51.6%)
|
5.84B
est: 1.99B (+193.6%)
|
3.18B
est: 1.20B (+165.5%)
|
6.45B
est: 1.60B (+303.0%)
|
1.49B
est: 2.12B (-29.7%)
|
2.42B
est: 2.07B (+17.3%)
|
3.01B
est: 2.31B (+30.1%)
|
5.10B
est: 2.23B (+129.0%)
|
2.33B
2.20B – 2.43B
+4.7% YoY
|
2.86B
2.66B – 2.95B
+22.7% YoY
|
2.61B
2.61B – 2.62B
-8.7% YoY
|
2.57B
2.40B – 2.66B
-1.8% YoY
|
| EBITDA |
587.26M
est: 847.86M (-30.7%)
|
481.69M
est: 525.29M (-8.3%)
|
483.43M
est: 502.31M (-3.8%)
|
458.64M
est: 475.81M (-3.6%)
|
738.99M
est: 660.07M (+12.0%)
|
531.42M
est: 397.85M (+33.6%)
|
890.47M
est: 531.28M (+67.6%)
|
643.84M
est: 703.06M (-8.4%)
|
1.07B
est: 734.50M (+45.3%)
|
1.45B
est: 821.99M (+76.5%)
|
1.45B
est: 792.29M (+83.3%)
|
829.51M
782.10M – 863.89M
+4.7% YoY
|
1.02B
944.61M – 1.05B
+22.7% YoY
|
929.02M
926.17M – 931.86M
-8.7% YoY
|
912.07M
853.18M – 944.13M
-1.8% YoY
|
| EBIT |
561.22M
est: 847.86M (-33.8%)
|
448.89M
est: 525.29M (-14.5%)
|
447.08M
est: 502.31M (-11.0%)
|
421.48M
est: 475.81M (-11.4%)
|
738.99M
est: 660.07M (+12.0%)
|
531.42M
est: 397.85M (+33.6%)
|
890.47M
est: 531.28M (+67.6%)
|
643.84M
est: 703.06M (-8.4%)
|
1.07B
est: 732.67M (+45.7%)
|
1.45B
est: 819.94M (+76.9%)
|
1.43B
est: 790.32M (+80.9%)
|
827.45M
780.16M – 861.74M
+4.7% YoY
|
1.01B
942.26M – 1.04B
+22.7% YoY
|
926.70M
923.87M – 929.54M
-8.7% YoY
|
909.80M
851.06M – 941.78M
-1.8% YoY
|
| Net Income |
438.61M
est: 409.49M (+7.1%)
|
393.53M
est: 365.00M (+7.8%)
|
379.99M
est: 369.17M (+2.9%)
|
255.71M
est: 340.98M (-25.0%)
|
565.43M
est: 562.61M (+0.5%)
|
434.46M
est: 406.25M (+6.9%)
|
713.06M
est: 645.62M (+10.4%)
|
506.83M
est: 499.45M (+1.5%)
|
821.87M
est: 908.46M (-9.5%)
|
1.12B
est: 1.03B (+8.4%)
|
1.24B
est: 1.07B (+15.6%)
|
1.07B
1.01B – 1.09B
+0.1% YoY
|
1.13B
1.06B – 1.19B
+5.4% YoY
|
1.18B
1.07B – 1.30B
+4.4% YoY
|
1.33B
1.21B – 1.39B
+12.4% YoY
|
| SGA |
272.47M
est: 349.83M (-22.1%)
|
293.46M
est: 216.74M (+35.4%)
|
287.24M
est: 207.26M (+38.6%)
|
293.43M
est: 196.32M (+49.5%)
|
294.44M
est: 272.35M (+8.1%)
|
299.03M
est: 164.15M (+82.2%)
|
329.34M
est: 219.21M (+50.2%)
|
353.27M
est: 290.09M (+21.8%)
|
391.77M
est: 274.19M (+42.9%)
|
424.15M
est: 306.85M (+38.2%)
|
370.64M
est: 295.77M (+25.3%)
|
309.66M
291.97M – 322.50M
+4.7% YoY
|
379.82M
352.63M – 390.91M
+22.7% YoY
|
346.81M
345.75M – 347.87M
-8.7% YoY
|
340.48M
318.50M – 352.45M
-1.8% YoY
|
| EPS |
0.59
est: 0.56 (+6.2%)
|
0.53
est: 0.50 (+7.1%)
|
0.52
est: 0.50 (+3.9%)
|
0.35
est: 0.46 (-24.3%)
|
0.77
est: 0.76 (+0.9%)
|
0.59
est: 0.55 (+7.1%)
|
0.97
est: 0.88 (+10.8%)
|
0.69
est: 0.68 (+1.2%)
|
1.11
est: 1.23 (-9.6%)
|
1.52
est: 1.41 (+7.5%)
|
1.68
est: 1.47 (+14.6%)
|
1.42
1.36 – 1.47
-3.1% YoY
|
1.50
1.43 – 1.59
+5.7% YoY
|
1.59
1.44 – 1.74
+5.6% YoY
|
1.78
1.63 – 1.86
+12.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 5/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 4/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Massimo Antonio Doris | Chief Executive Officer & Director | 1M | male |
| Angelo Lietti | Chief Financial Officer & Manager for Preparing Corporate Accounting Documents | — | male |
| Ettore Parlato Spadafora | Head of Legal & Compliance Control | — | male |
| Alessandra Lanzone | Head of Investor Relations | — | female |
| Luca Maria Rovere | Secretary to the Board of Directors | — | male |
| Roberto Brega | Head of Compliance | — | male |
| Lisa Maxon | Executive of Investor Relations | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BMED.MI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
